Chromosomal Microarray Analysis Results From Pregnancies With Various Ultrasonographic Anomalies.

OBJECTIVE To examine chromosomal microarray analysis results in pregnancies with various ultrasonographic anomalies and to characterize the copy number variants in diverse fetal phenotypes. METHODS We retrospectively examined chromosomal microarray analyses of amniocenteses performed nationwide as a result of fetal ultrasonographic anomalies (structural defects, fetal growth restriction, and polyhydramnios) between January 2013 and September 2017. The rate of abnormal chromosomal microarray findings was compared between the different phenotypes and with a previously described control population of 15,225 pregnancies with normal ultrasonographic findings. RESULTS Clinically significant chromosomal microarray aberrations were detected in 272 of 5,750 pregnancies (4.7%): 115 (2%) karyotype-detectable and 157 (2.7%) submicroscopic. Most commonly detected copy number variants were 22q11.21 deletions (0.4%) followed by 22q11.21 gain of copy number (0.2%). Specific copy number variants detected among pregnancies with abnormal ultrasonographic findings were up to 20-fold more prevalent compared with low-risk pregnancies. Some variants were associated with specific phenotypes (eg, 22q11.21 microdeletions with cardiovascular and 17q12 microdeletions with genitourinary defects). CONCLUSION The rate of abnormal amniotic chromosomal microarray analysis results is twice that of karyotypic abnormalities in pregnancies with various abnormal ultrasonographic findings.

• Publication year

  2018

• Venue

  Obstetrics and Gynecology

• Publication date

  2018-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/AOG.0000000000002975PMID 30399107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-visualization of fetal gallbladder in microarray era – a retrospective cohort study and review of the literature

  2019cited by this paper
• Isolated fetal horseshoe kidney does not seem to increase the risk for abnormal chromosomal microarray results.

  2018cited by this paper
• Microarray analysis in pregnancies with isolated unilateral kidney agenesis

  2018cited by this paper
• ACOG and SMFM guidelines for prenatal diagnosis: Is karyotyping really sufficient?

  2018cited by this paper
• Prenatal microarray analysis in right aortic arch—a retrospective cohort study and review of the literature

  2018cited by this paper
• When genotype is not predictive of phenotype: implications for genetic counseling based on 21,594 chromosomal microarray analysis examinations

  2017cited by this paper
• Association of aberrant right subclavian artery with abnormal karyotype and microarray results

  2017cited by this paper
• Cut‐off value of nuchal translucency as indication for chromosomal microarray analysis

  2017cited by this paper
• Risk of fetal loss associated with invasive testing following combined first‐trimester screening for Down syndrome: a national cohort of 147 987 singleton pregnancies

  2016cited by this paper
• ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013

  2013cited by this paper
• The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature

  2013cited by this paper
• Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies

  2012cited by this paper
• Estimates of penetrance for recurrent pathogenic copy-number variations

  2012cited by this paper
• Chromosomal microarray versus karyotyping for prenatal diagnosis.

  2012cited by this paper
• American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants

  2011cited by this paper
• A Copy Number Variation Morbidity Map of Developmental Delay

  2011cited by this paper
• Introducing array comparative genomic hybridization into routine prenatal diagnosis practice: a prospective study on over 1000 consecutive clinical cases

  2011cited by this paper
• Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

  2010cited by this paper
• Genomic Imbalances in Neonates With Birth Defects: High Detection Rates by Using Chromosomal Microarray Analysis

  2008cited by this paper
• Strong Association of De Novo Copy Number Mutations with Autism

  2007cited by this paper
• Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases.

  2006cited by this paper

• Advancing Prenatal Diagnosis: From Conventional Karyotyping to Genome-Wide CNV Analysis.

  2026cites this paper
• Chromosomal miscarriage and pregnancy outcomes in recurrent pregnancy loss

  2025cites this paper
• Optical Genome Mapping for Prenatal Diagnosis in Fetuses With Structural Anomalies

  2025influential citation
• Identification of Novel Epilepsy Genetics and Development of Advanced Diagnostic Approaches

  2025cites this paper
• Investigation and Care of a Small‐for‐Gestational‐Age Fetus and a Growth Restricted Fetus (Green‐top Guideline No. 31)

  2024cites this paper
• Prenatal diagnosis and perinatal findings of 17q12 microdeletion encompassing HNF1B in a fetus with bilateral hyperechogenic kidneys on fetal ultrasound and mild renal abnormality after birth, and a review of the literature of prenatal diagnosis of 17q12 microdeletion.

  2024cites this paper
• Exploring the factors affecting classification and reporting of uncertain prenatal microarray findings, using a “virtual fetus” model‐a pilot study

  2024cites this paper
• Prenatal genetic investigation in pregnancies with oligohydramnios: Results from a single referral medical center.

  2024cites this paper
• DNA concentrations in amniotic fluid according to gestational age and fetal sex: data from 2573 samples

  2024cites this paper
• The effect of opting‐in versus opting‐out forming on the rate of reported variants of questionable significance in prenatal microarray

  2024cites this paper
• Classifying and evaluating fetuses with multicystic dysplastic kidney in etiologic studies

  2023cites this paper
• Directive clinique no 442 : Retard de croissance intra-utérin : Dépistage, diagnostic et prise en charge en contexte de grossesse monofœtale.

  2023cites this paper
• Guideline No. 442: Fetal Growth Restriction: Screening, Diagnosis, and Management in Singleton Pregnancies.

  2023cites this paper
• Chromosomal abnormalities in fetuses with congenital heart disease: a meta-analysis

  2023cites this paper
• Comparative Genomic Hybridization to Microarrays in Fetuses with High-Risk Prenatal Indications: Polish Experience with 7400 Pregnancies

  2022cites this paper
• Prenatal and postnatal chromosomal microarray analysis in 885 cases of various congenital heart defects

  2022cites this paper
• Molecular Approaches in Fetal Malformations, Dynamic Anomalies and Soft Markers: Diagnostic Rates and Challenges—Systematic Review of the Literature and Meta-Analysis

  2022cites this paper
• Evaluation of genetic variants using chromosomal microarray analysis for fetuses with polyhydramnios

  2022cites this paper
• Fetal growth restriction: associated genetic etiology and pregnancy outcomes in a tertiary referral center

  2022cites this paper
• Chromosomal Abnormalities and Pregnancy Outcomes for Fetuses With Gastrointestinal Tract Obstructions

  2022cites this paper
• Prenatal Diagnosis Using Chromosomal Microarray Analysis in High-Risk Pregnancies

  2022cites this paper
• Residual risk of noninvasive prenatal screening in pregnancies with ultrasound anomalies.

  2022cites this paper
• Chromosome Microarray Testing (Non-Oncology Conditions)

  2022cites this paper
• 17q12 Recurrent Deletions and Duplications: Description of a Case Series with Neuropsychiatric Phenotype

  2021cites this paper
• Precision medicine in women with epilepsy: The challenge, systematic review, and future direction.

  2021cites this paper
• Diagnostic accuracy and value of chromosomal microarray analysis for chromosomal abnormalities in prenatal detection

  2021cites this paper
• Should prenatal chromosomal microarray analysis be offered for isolated fetal growth restriction? A French multicenter study.

  2021cites this paper
• Diagnostic value of systematic ultrasonography for trisomy 18 syndrome in fetuses before 16 weeks gestation

  2021cites this paper
• Fetal Aberrant Right Subclavian Artery: Associated Anomalies, Genetic Etiology, and Postnatal Outcomes in a Retrospective Cohort Study

  2021cites this paper
• FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: Best practice advice for screening, diagnosis, and management of fetal growth restriction

  2021cites this paper
• Chromosomal microarray analysis in fetuses with high-risk prenatal indications: A retrospective study in China.

  2021cites this paper
• The effect of polyhydramnios degree on chromosomal microarray results: a retrospective cohort analysis of 742 singleton pregnancies

  2021cites this paper
• Chromosomal Microarray Analysis in Pregnancies With Corpus Callosum or Posterior Fossa Anomalies

  2021cites this paper
• The yield of chromosomal microarray analysis among pregnancies terminated due to fetal malformations

  2020cites this paper
• Chromosome Microarray Testing (Non-Oncology Conditions)

  2020cites this paper
• Diagnostic accuracy and value of chromosomal microarray analysis for chromosomal abnormalities in prenatal detection: a prospective clinical study

  2020cites this paper
• The current state of prenatal detection of genetic conditions in congenital heart defects

  2020cites this paper
• The Yield of Chromosomal Microarray in Pregnancies Complicated with Fetal Growth Restriction Can Be Predicted According to Clinical Parameters

  2020cites this paper
• Microarray analysis in fetuses with duodenal obstruction: It is not just trisomy 21

  2020cites this paper
• Performance of diagnostic ultrasound to identify causes of hydramnios

  2020cites this paper
• Chromosomal microarray should be performed for cases of fetal short long bones detected prenatally

  2020cites this paper
• Polyhydramnios and abnormal foetal heart rate patterns in a foetus with Prader-Willi syndrome: A case report

  2020cites this paper
• Chromosome Microarray Testing (Non-Oncology Conditions)

  2019cites this paper
• Chromosome Microarray Testing (Non-Oncology Conditions) (for Tennessee Only)

  2019cites this paper
• Microarray findings in pregnancies with oligohydramnios – a retrospective cohort study and literature review

  2019cites this paper
• Chromosome Microarray Testing (Non-Oncology Conditions)

  2019cites this paper
• In Reply.

  2019cites this paper
• Chromosomal Microarray Analysis Results From Pregnancies With Various Ultrasonographic Anomalies.

  2019cites this paper
• Chromosome Microarray Testing (Non-Oncology Conditions) – Commercial Medical Policy

  2018cites this paper
• Chromosome Microarray Testing (Non-Oncology Conditions) – Commercial Medical Policy

  2018cites this paper
• Chromosome Microarray Testing (Non-Oncology Conditions) (for North Carolina Only)

  year unknowncites this paper
• Chromosome Microarray Testing (Non-Oncology Conditions)

  year unknowncites this paper